NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

AcbaC.00113.a: 3-oxoacyl-[acyl-carrier-protein] synthase 1

Target Characteristics

from organism: Acinetobacter baumannii AB5075-UW
most recent status: cloned
center reference id: AcbaC.00113.a
is community request: True
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
unclassified

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
AcbaC.00113.a.B1.GE38586 full length 1 409 GE38586
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

External Resources

Resource Reference ID
GenBank: AKA32778.1
PATRIC ID: fig|470.1345.peg.3016
PGAT: acinetobacter:ABUW_3065
RefSeq: WP_000832710.1
UniProt: V5VFT6

Enzyme & Pathway Information

Pathway Pathway ID EC Number
biotin biosynthesis I BIOTIN-BIOSYNTHESIS-PWY 2.3.1.179
fatty acid elongation -- saturated FASYN-ELONG-PWY 2.3.1.179
superpathway of fatty acid biosynthesis initiation (E. coli) FASYN-INITIAL-PWY 2.3.1.179
(5Z)-dodecenoate biosynthesis I PWY0-862 2.3.1.179
superpathway of fatty acid biosynthesis I (E. coli) PWY0-881 2.3.1.179
stearate biosynthesis III (fungi) PWY3O-355 2.3.1.179
superpathway of fatty acid biosynthesis II (plant) PWY-5156 2.3.1.179
petroselinate biosynthesis PWY-5367 2.3.1.179
palmitate biosynthesis II (bacteria and plants) PWY-5971 2.3.1.179
cis-vaccenate biosynthesis PWY-5973 2.3.1.179
superpathway of mycolate biosynthesis PWY-6113 2.3.1.179
palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate) PWY-6282 2.3.1.179
superpathway of unsaturated fatty acids biosynthesis (E. coli) PWY-6284 2.3.1.179
superpathway of fatty acids biosynthesis (E. coli) PWY-6285 2.3.1.179
8-amino-7-oxononanoate biosynthesis I PWY-6519 2.3.1.179
octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast) PWY-7388 2.3.1.179
gondoate biosynthesis (anaerobic) PWY-7663 2.3.1.179
oleate biosynthesis IV (anaerobic) PWY-7664 2.3.1.179
(5Z)-dodecenoate biosynthesis II PWY-7858 2.3.1.179
superpathway of fatty acid biosynthesis II (plant) PWY-5156 2.3.1.41
fatty acid biosynthesis initiation III PWY-5965 2.3.1.41
fatty acid biosynthesis initiation II PWY-5966 2.3.1.41
stearate biosynthesis II (bacteria and plants) PWY-5989 2.3.1.41
superpathway of mycolate biosynthesis PWY-6113 2.3.1.41
mycolate biosynthesis PWYG-321 2.3.1.41

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MKRVVITGMG INSCIGNSLE EVTHSLKNGI SGTRFNPTYA ELNFKSHVSA AAEQDFDNID RKLKRFMGVC AMYAYNSAVA AVEHAGLKAE DLADNPRYGI AGGSGGGSTA SVVEMTELLE TKGARKVGPF FVPRNMTNTI TANVGVAFKL QGIAHSIASA CATSADAIGY AYNLIALGKQ DLMLAGGGEE DHWSQSLLFD AMGALCSKYN DTPETASRPY SKDRDGFVIA GGGGFVVLES LEHAQARGAN ILAEVVAYAA NSDGADMVAP SGEGATRCIL MALEEAKQHG VDKIDYVNTH GTSTPAGDVT ELKAMERAFG EGKVPPLSST KSMTGHSLGA AGVHEAIYSV LMLQNDFIAP NINVTELDEG TEGFDIVLEK RDTKLNTVMS NSFGFGGVNA CLIFKKWDA

NT Sequence
ATGAAACGTG TTGTAATCAC TGGTATGGGT ATTAACTCAT GTATCGGTAA CTCTTTAGAA GAAGTTACTC ATTCACTTAA AAATGGAATC TCCGGGACAC GTTTTAACCC AACTTATGCT GAACTCAATT TTAAAAGTCA TGTCAGCGCT GCGGCAGAAC AAGATTTTGA CAATATTGAT CGTAAATTAA AACGGTTCAT GGGCGTATGT GCAATGTACG CTTATAACTC TGCTGTTGCA GCCGTTGAAC ATGCTGGCTT AAAAGCAGAA GATTTAGCAG ATAATCCACG TTATGGTATT GCCGGTGGTT CAGGCGGTGG TTCAACTGCT TCTGTTGTAG AAATGACTGA ACTTTTAGAA ACTAAAGGTG CTCGTAAAGT TGGTCCTTTC TTTGTTCCAC GTAATATGAC AAATACAATC ACTGCAAACG TGGGTGTAGC ATTTAAACTT CAAGGTATTG CTCACTCAAT TGCAAGTGCT TGTGCAACTT CTGCAGACGC AATTGGTTAT GCATATAACC TTATCGCTCT AGGCAAACAA GATCTTATGC TTGCTGGTGG TGGTGAAGAA GATCACTGGT CTCAAAGCCT ATTGTTTGAT GCAATGGGTG CTTTGTGTTC TAAATACAAC GACACACCTG AAACAGCGTC TCGTCCATAT TCTAAAGACC GTGACGGTTT CGTTATTGCT GGCGGTGGCG GTTTCGTTGT TCTTGAATCT CTTGAACATG CTCAAGCACG TGGTGCAAAT ATTCTTGCTG AAGTTGTTGC TTATGCTGCA AACAGTGACG GCGCTGACAT GGTAGCTCCA AGTGGTGAAG GTGCAACTCG CTGTATCTTG ATGGCTCTTG AAGAAGCGAA ACAACACGGC GTAGATAAAA TTGACTATGT AAATACGCAT GGTACTTCTA CACCAGCAGG TGACGTGACT GAGCTTAAAG CAATGGAACG TGCTTTCGGT GAAGGTAAAG TTCCACCTCT TAGTTCAACT AAATCTATGA CTGGTCACAG CCTAGGTGCT GCTGGTGTTC ATGAAGCAAT TTACTCTGTA TTAATGCTTC AAAATGACTT TATCGCGCCA AACATCAACG TGACTGAGCT TGATGAAGGT ACTGAAGGCT TTGATATTGT GCTTGAAAAA CGTGATACAA AATTGAATAC TGTAATGAGT AACAGTTTTG GCTTTGGCGG TGTTAACGCT TGCCTAATTT TCAAGAAGTG GGATGCATAA

© 2020 Seattle Children's Research Institute. All rights reserved.